Tenderwize
Wróć do wyszukiwania

Open House Discount Contracts for Ranibizumab (Vial)

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 218 days left·Open·Supplies
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Ranibizumab, als Durchstechflasche, ATC S01LA04

50/100

Ocena szansy

Needs reviewLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

50 / 100

Złożoność

25 / 100

Czynniki ryzyka

The buyer reserves the right to replace open-house contracts with exclusive contracts from EU tenders, which would auto...

As an open-house model, there is no guaranteed purchase volume or spend; contracts are purely discount agreements.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Provision of non-exclusive discount contracts for the active substance Ranibizumab (ATC S01LA04) as a vial.
  • Contracts are open to all interested pharmaceutical companies meeting the eligibility criteria.
Pokaż pełne podsumowanie

This is an open-house model for non-exclusive discount contracts (Rabattverträge) for the pharmaceutical product Ranibizumab (ATC S01LA04) as a vial, offered by AOK Rheinland-Pfalz/Saarland. The contract period is from 01.06.2025 to 31.05.2027, with the possibility to join at any month start. The first submission deadline for the initial contract start is 30.04.2025. No estimated value is provided. This is not a classic procurement but a voluntary transparency publication.

Ryzyka

The buyer reserves the right to replace open-house contracts with exclusive contracts from EU tenders, which would auto...

As an open-house model, there is no guaranteed purchase volume or spend; contracts are purely discount agreements.

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Pharmaceutical company must offer authorized and marketable drugs in Germany.

Administrative

  • Drugs must be listed in the Lauer-Taxe as marketable; otherwise, evidence from AMIce database or other documentation is required.
  • Submission of signed contract documents by specified deadlines.

Wymagania mogą być niepełne.

Zamawiający

Lokalizacja

Eisenberg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE271900642

Działalność

Health

Części (1)

LOT-0001

Open House Discount Contracts for Ranibizumab (Vial)

Non-exclusive discount contracts for Ranibizumab (ATC S01LA04) as a vial. Maximum contract duration 24 months from 01.06.2025 to 31.05.2027. First contract conclusion possible on 01.06.2025. All contracts end at the latest 24 months after the earliest start date. Open to all interested pharmaceutical companies offering authorized and marketable drugs in Germany.

SuppliesEU fundedElectronic submission

Lokalizacja

Eisenberg, Germany

Czas trwania

May 2025 - May 2027

Kategoria

Pharmaceutical products

Termin

Expired Apr 30, 2025

Szczegóły zamówienia

Data publikacji
10 Apr 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
236800-2025

Dokumenty (1)

Podobne przetargi